{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:16:25Z","timestamp":1793301385762,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.det.2024.12.004","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T07:40:02Z","timestamp":1736322002000},"page":"179-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"43","author":[{"given":"James","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Frew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.det.2024.12.004_bib1","first-page":"8","article-title":"Hidradenitis suppuratia","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"10.1016\/j.det.2024.12.004_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bjd\/ljad345","article-title":"Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape","volume":"190","author":"Krueger","year":"2024","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.004_bib3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","article-title":"Histology of hidradenitis suppurativa","volume":"34","author":"Jemec","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.12.004_bib4","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","article-title":"Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa","volume":"136","author":"Hotz","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.004_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.13449","article-title":"IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa","volume":"201","author":"Fletcher","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.det.2024.12.004_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2024.12.004_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/1744666X.2016.1221762","article-title":"Adalimumab for the treatment of hidradenitis suppurativa\/acne inversa","volume":"12","author":"Zouboulis","year":"2016","journal-title":"Expet Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.det.2024.12.004_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.16019","article-title":"Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop","volume":"178","author":"Hessam","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib10","article-title":"A\u00a0systematic review and critical evaluation of immunohistochemical associations in hidradenitis suppurativa","volume":"7","author":"Frew","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.det.2024.12.004_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jid.2020.06.019","article-title":"A\u00a0systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance","volume":"141","author":"Frew","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/exd.14092","article-title":"Beyond antibodies: B cells in Hidradenitis Suppurativa: bystanders, contributors or therapeutic targets?","volume":"29","author":"Frew","year":"2020","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.004_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bjd\/ljad184","article-title":"Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin","volume":"189","author":"Moran","year":"2023","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2024.12.004_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00011-017-1074-y","article-title":"The critical role of macrophages i the pathogenesis of hidradenitis suppurativa","volume":"66","author":"Shah","year":"2017","journal-title":"Inflamm Res"},{"key":"10.1016\/j.det.2024.12.004_bib15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-015-1596-5","article-title":"Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients","volume":"307","author":"Riis","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2024.12.004_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"issue":"23","key":"10.1016\/j.det.2024.12.004_bib18","article-title":"The role of hormones in hidradenitis suppurativa: a systematic review","volume":"23","author":"Abu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijwd.2020.09.002","article-title":"Characterizing perimenstrual flares of hidradenitis suppurativa","volume":"6","author":"Collier","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jid.2021.06.008","article-title":"Sex bias and autoimmune diseases","volume":"142","author":"Xing","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib21","first-page":"205","article-title":"Sex-based differences in autoimmune diseases","volume":"52","author":"Ortona","year":"2016","journal-title":"Annali dell'Istituto superiore di sanita"},{"key":"10.1016\/j.det.2024.12.004_bib22","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1038\/s41467-020-17260-y","article-title":"Androgens predispose males to monocyte-mediated immunopathology by inducing the expression of leukocyte recruitment factor CXCL1","volume":"11","author":"Sellau","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.det.2024.12.004_bib23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1080\/08820139.2021.1915329","article-title":"The imbalance in Th17 and treg cells in polycystic ovarian syndrome patients with autoimmune thyroiditis","volume":"51","author":"Ma","year":"2022","journal-title":"Immunol Invest"},{"key":"10.1016\/j.det.2024.12.004_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/exd.14789","article-title":"Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: a prospective cohort study","volume":"32","author":"Flora","year":"2023","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ced\/llad385","article-title":"Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use","volume":"49","author":"Huang","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.004_bib26","first-page":"239","article-title":"The role of androgens and estrogens in hidradenitis suppurativa - a systematic review","volume":"24","author":"Riis","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"issue":"3","key":"10.1016\/j.det.2024.12.004_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.15904","article-title":"Adipokines are dysregulated in patients with hidradenitis suppurativa","volume":"178","author":"Malara","year":"2018","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.12.004_bib28","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2017-01474","article-title":"Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women","volume":"102","author":"Hetem\u00e4ki","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib29","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1152\/ajpendo.00293.2017","article-title":"Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women","volume":"314","author":"Marchand","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.det.2024.12.004_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40257-023-00756-w","article-title":"Effects of exercise and dietary modifications on hidradenitis suppurativa: a systematic review","volume":"24","author":"Weber","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"10.1016\/j.det.2024.12.004_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/ijd.15910","article-title":"Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects","volume":"61","author":"Mintoff","year":"2022","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.004_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdin.2020.05.005","article-title":"Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence","volume":"1","author":"Frew","year":"2020","journal-title":"JAAD Int"},{"key":"10.1016\/j.det.2024.12.004_bib33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamadermatol.2023.0486","article-title":"Patient perspectives of health system barriers to accessing care for hidradenitis suppurativa: a qualitative study","volume":"159","author":"Barnes","year":"2023","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.det.2024.12.004_bib34","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.2731","article-title":"Hidradenitis suppurativa: absence of hyperhidrosis but presence of a proinflammatory signature in patients' sweat","volume":"102","author":"Frings","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2024.12.004_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.det.2024.12.004_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/jme.0.0250149","article-title":"Role of aromatase in sex steroid action","volume":"25","author":"Simpson","year":"2000","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.det.2024.12.004_bib37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.15904","article-title":"Adipokines are dysregulated in patients with hidradenitis suppurativa","volume":"178","author":"Malara","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2008.08655.x","article-title":"Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation","volume":"159","author":"Johnston","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.det.2024.12.004_bib40","first-page":"2549","article-title":"Correlations of SOX9 expression with serum IGF1 and inflammatory cytokines IL-1\u03b1 and IL-6 in skin lesions of patients with acne","volume":"22","author":"Ji","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.det.2024.12.004_bib41","first-page":"159","article-title":"Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease","volume":"61","author":"Street","year":"2004","journal-title":"Horm Res"},{"key":"10.1016\/j.det.2024.12.004_bib42","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1111\/ced.13954","article-title":"Hidradenitis suppurativa and diabetes: big data bias masks a true association","volume":"44","author":"Frew","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DMSO.S405374","article-title":"Insulin stimulates IL-23 expression in human adipocytes: a possible explanation for the higher prevalence of psoriasis in obesity","author":"Di Vincenzo","year":"2023","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"10.1016\/j.det.2024.12.004_bib44","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3390\/ijms24086969","article-title":"Metformin treatment of hidradenitis suppurativa: effect on metabolic parameters, inflammation, cardiovascular risk biomarkers, and immune mediators","volume":"24","author":"Hambly","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.det.2024.12.004_bib45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/oby.2010.22","article-title":"The human visceral fat depot has a unique inflammatory profile","volume":"18","author":"Alvehus","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.det.2024.12.004_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.2012.04401.x","article-title":"Associations between visceral adipose tissue, inflammation and sex steroid concentrations in men","volume":"78","author":"Gautier","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.det.2024.12.004_bib47","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamadermatol.2020.1281","article-title":"Disease trajectories for hidradenitis suppurativa in the Danish Population","volume":"156","author":"Kj\u00e6rsgaard Andersen","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"9","key":"10.1016\/j.det.2024.12.004_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls","volume":"153","author":"Ring","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib49","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.15597","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","volume":"33","author":"Ring","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2024.12.004_bib50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jid.2021.05.036","article-title":"Altered skin and gut microbiome in hidradenitis suppurativa","volume":"142","author":"McCarthy","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"issue":"10","key":"10.1016\/j.det.2024.12.004_bib51","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/exd.14141","article-title":"A\u00a0systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa","volume":"30","author":"Williams","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bjd.20750","article-title":"Antimicrobial peptides in hidradenitis suppurativa: a systematic review","volume":"186","author":"Yao","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bjd\/ljad184","article-title":"Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin","volume":"189","author":"Moran","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.861241","article-title":"The genomic architecture of hidradenitis suppurativa","volume":"13","author":"Pace","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.det.2024.12.004_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15087","article-title":"Gram-negative anaerobes elicit a robust keratinocytes immune response with potential insights into HS pathogenesis","volume":"33","author":"Williams","year":"2024","journal-title":"Exp Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.12.004_bib56","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/exd.14665","article-title":"Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa","volume":"31","author":"Tatian","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2019.07.070","article-title":"Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts","volume":"82","author":"Nofal","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.004_bib58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamadermatol.2023.6201","article-title":"Efficacy and durability of intravenous ertapenem therapy for recalcitrant hidradenitis suppurativa","volume":"160","author":"Nosrati","year":"2024","journal-title":"JAMA Dermatol."},{"issue":"11","key":"10.1016\/j.det.2024.12.004_bib59","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF Therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib60","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaad.2020.05.007","article-title":"The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: an open-label cohort study","volume":"83","author":"Frew","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.004_bib61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"von Laffert","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib62","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.det.2024.12.004_bib63","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.det.2024.12.004_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14894","article-title":"Mast cells are upregulated in hidradenitis suppurativa tissue, associated with epithelialized tunnels and normalized by spleen tyrosine kinase antagonism","volume":"33","author":"Flora","year":"2024","journal-title":"Exp Dermatol"},{"issue":"72","key":"10.1016\/j.det.2024.12.004_bib65","article-title":"Disease associated monocytes contribute to the inflammatory milieu in hidradenitis suppurativa and have dysregulated expression of transposable elements","volume":"210","author":"Dimitrion","year":"2023","journal-title":"J\u00a0Immunol"},{"issue":"19","key":"10.1016\/j.det.2024.12.004_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139930","article-title":"Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis","volume":"5","author":"Gudjonsson","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib67","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jid.2019.08.453","article-title":"Enrichment of plasma cells in the peripheral blood and skin of patients with hidradenitis suppurativa","volume":"140","author":"Musilova","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.004_bib68","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"issue":"23","key":"10.1016\/j.det.2024.12.004_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404503121","article-title":"Tissue comparability and bias in hidradenitis suppurativa transcriptomic studies","volume":"121","author":"Nebo","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216249","article-title":"The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin","volume":"14","author":"Coates","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.det.2024.12.004_bib71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bjd.20750","article-title":"Antimicrobial peptides in hidradenitis suppurativa: a systematic review","volume":"186","author":"Yao","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.004_bib72","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/bjd\/ljad273","article-title":"Aberrant expression of interleukin-17A is contributes to the pathogenesis of hidradenitis suppurativa","volume":"189","author":"Chu","year":"2023","journal-title":"Br J Dermatol"},{"issue":"508","key":"10.1016\/j.det.2024.12.004_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5908","article-title":"Neutrophil extracellular traps, b cells and type 1 interferons contribute to immune dysregulation in hidradenitis suppurativa","volume":"11","author":"Byrd","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.det.2024.12.004_bib74","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jid.2021.07.187","article-title":"Autoantibodies present in hidradenitis suppurativa correlate with disease severity and promote the release of proinflammatory cytokines in macrophages","volume":"142","author":"Carmona-Rivera","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib75","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jid.2021.08.400","article-title":"Autoantibody-mediated macrophage responses provide the missing link between innate and adaptive immune dysfunction in hidradenitis suppurativa","volume":"142","author":"Frew","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jid.2022.08.051","article-title":"Disease association of anti\u2012carboxyethyl lysine autoantibodies in hidradenitis suppurativa","volume":"143","author":"Macchiarella","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"issue":"7","key":"10.1016\/j.det.2024.12.004_bib77","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1084\/jem.20181994","article-title":"Human lymphoid organ cDC2 and macrophages play complementary roles in T follicular helper responses","volume":"216","author":"Durand","year":"2019","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.det.2024.12.004_bib78","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jaci.2023.05.012","article-title":"Single-cell transcriptomics suggest distinct upstream drivers of IL-17A\/F in hidradenitis versus psoriasis","volume":"152","author":"Kim","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.det.2024.12.004_bib79","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/exd.14092","article-title":"Beyond antibodies: B cells in hidradenitis suppurativa: bystanders, contributors or therapeutic targets?","volume":"29","author":"Frew","year":"2020","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.004_bib80","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.jaci.2020.12.651","article-title":"Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa","volume":"147","author":"Navrazhina","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.det.2024.12.004_bib81","article-title":"Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa","volume":"9","author":"Lowe","year":"2024","journal-title":"JCI insight"},{"key":"10.1016\/j.det.2024.12.004_bib82","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jaci.2022.02.003","article-title":"Insights into hidradenitis suppurativa","volume":"149","author":"van Straalen","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.det.2024.12.004_bib83","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.3390\/ijms22084254","article-title":"Estrogen receptor functions and pathways at the vascular immune interface","volume":"22","author":"Dama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.det.2024.12.004_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15252\/emmm.202216758","article-title":"FAM3C\/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice","volume":"15","author":"Malik","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.det.2024.12.004_bib85","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/bjd\/ljad273","article-title":"Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa","volume":"189","author":"Chu","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14894","article-title":"Mast cells are upregulated in hidradenitis suppurativa tissue, associated with epithelialized tunnels and normalized by spleen tyrosine kinase antagonism","volume":"33","author":"Flora","year":"2024","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.004_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169225","article-title":"Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa","volume":"134","author":"van Straalen","year":"2024","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.det.2024.12.004_bib88","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/exd.13978","article-title":"Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa\/acne inversa","volume":"28","author":"Frew","year":"2019","journal-title":"Exp Dermatol"},{"issue":"11","key":"10.1016\/j.det.2024.12.004_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282763","article-title":"Human dermal fibroblast subpopulations and epithelial mesenchymal transition signals in hidradenitis suppurativa tunnels are normalized by spleen tyrosine kinase antagonism in\u00a0vivo","volume":"18","author":"Flora","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.det.2024.12.004_bib90","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.004_bib91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1101\/gad.233247.113","article-title":"SOX9: a stem cell transcriptional regulator of secreted niche signaling factors","volume":"28","author":"Kadaja","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.det.2024.12.004_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar880","article-title":"Sox9 represses gene expression via histone deacetylase activity","volume":"5","author":"Tsuda","year":"2003","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.det.2024.12.004_bib93","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.det.2015.07.002","article-title":"The genetics of hidradenitis suppurativa","volume":"34","author":"Ingram","year":"2016","journal-title":"Dermatol Clin"},{"issue":"12","key":"10.1016\/j.det.2024.12.004_bib94","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamadermatol.2020.3630","article-title":"Contribution of genetics to the susceptibility to hidradenitis suppurativa in a large, cross-sectional Dutch twin cohort","volume":"156","author":"van Straalen","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.004_bib95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/bjd.20654","article-title":"Evidence of gene-gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins","volume":"186","author":"Kjaersgaard Andersen","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6007","key":"10.1016\/j.det.2024.12.004_bib96","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.det.2024.12.004_bib97","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.12098","article-title":"Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology","volume":"22","author":"Melnik","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib98","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.det.2024.12.004_bib99","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1111\/ced.13906","article-title":"Nicastrin haploinsufficiency alters expression of type I interferon-stimulated genes: the relationship to familial hidradenitis suppurativa","volume":"44","author":"Cao","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000339773","article-title":"Can animal skin diseases or current transgenic mice serve as a model for hidradenitis suppurativa?","volume":"225","author":"Van der Zee","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2024.12.004_bib101","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.devcel.2004.09.014","article-title":"Gamma-secretase functions through notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis","volume":"7","author":"Pan","year":"2004","journal-title":"Dev Cell"},{"issue":"10","key":"10.1016\/j.det.2024.12.004_bib102","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jid.2019.10.025","article-title":"Low prevalence of GSC gene mutations in a large cohort of predominantly caucasian patients with hidradenitis suppurativa","volume":"140","author":"Duchatelet","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib103","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bjd.15441","article-title":"A\u00a0systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa","volume":"177","author":"Frew","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib104","first-page":"203","article-title":"e al Increased expresson profile of NCSTN, Notch and PI3K\/AKT3 in Hidradenitis Suppurativ a","volume":"35","author":"Hessam","year":"2021","journal-title":"JEADV"},{"key":"10.1016\/j.det.2024.12.004_bib105","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/bjd.18593","article-title":"No evidence that impaired Notch signalling differentiates hidradenitis suppurativa from other inflammatory skin diseases","volume":"182","author":"Frew","year":"2020","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.12.004_bib106","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jamadermatol.2023.2217","article-title":"Genetic variants associated with hidradenitis suppurativa","volume":"159","author":"Sun","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib107","series-title":"An ancestrally diverse hs meta-analysis of nine hidradentiis suppurativa cohorts identified four risk loci","author":"Khan","year":"2023"},{"key":"10.1016\/j.det.2024.12.004_bib108","series-title":"Exploring the genomic landscape of hidradenitis suppurativa: a comprehensive genome wide association study from the VA\u2019S MVPi","author":"Wendland","year":"2023"},{"issue":"6","key":"10.1016\/j.det.2024.12.004_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.115.135400","article-title":"Sry-Independent overexpression of sox9 supports spermatogenesis and fertility in the mouse","volume":"93","author":"Ortega","year":"2015","journal-title":"Biol Reprod"},{"key":"10.1016\/j.det.2024.12.004_bib110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1095\/biolreprod.115.131276","article-title":"Gonadal identity in the absence of pro-testis factor SOX9 and pro-ovary factor beta-catenin in mice","volume":"93","author":"Nicol","year":"2015","journal-title":"Biol Reprod"},{"key":"10.1016\/j.det.2024.12.004_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721813","article-title":"Expression of sex hormone receptor and immune response genes in peripheral blood mononuclear cells during the menstrual cycle","volume":"12","author":"Brundin","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.det.2024.12.004_bib112","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s00018-009-0045-z","article-title":"Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases","volume":"66","author":"Dong","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.det.2024.12.004_bib113","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/ijd.14697","article-title":"Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis","volume":"59","author":"Phan","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib114","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s00018-009-0045-z","article-title":"Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases","volume":"66","author":"Dong","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.det.2024.12.004_bib115","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1172\/JCI86282","article-title":"An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes","volume":"127","author":"Yan","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.det.2024.12.004_bib116","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/exd.14273","article-title":"Histologic progression of acne inversa\/hidradenitis suppurativa: implications for future investigations and therapeutic intervention","volume":"30","author":"Dunstan","year":"2021","journal-title":"Exp Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.12.004_bib117","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jid.2021.02.742","article-title":"In-depth analysis of the hidradenitis suppurativa serum proteome identifies distinct inflammatory subtypes","volume":"141","author":"Navrazhina","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.004_bib118","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaad.2024.03.028","article-title":"Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis","volume":"91","author":"Pham","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2018.06.063","article-title":"Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa","volume":"80","author":"Golbari","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib120","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ced.14119","article-title":"Spironolactone therapy for hidradenitis suppurativa","volume":"45","author":"Quinlan","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib121","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A\u00a0case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.004_bib122","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s13555-023-00913-3","article-title":"Efficacy and safety of risankizumab for the treatment of hidradenitis suppurativa: a phase 2, randomized, placebo-controlled trial","volume":"13","author":"Kimball","year":"2023","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.det.2024.12.004_bib123","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/jdv.19252","article-title":"Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: a phase 2 randomized study","volume":"37","author":"Kimball","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2024.12.004_bib124","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jaad.2023.05.076","article-title":"A\u00a0proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativa","volume":"89","author":"Jepsen","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib125","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s13555-023-00956-6","article-title":"Emerging treatments and the clinical trial landscape for hidradenitis suppurativa part I: topical and systemic medical therapies","volume":"13","author":"Fragoso","year":"2023","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2024.12.004_bib126","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jid.2019.10.024","article-title":"A\u00a0phase II open-label study of bermekimab in patients with hidradenitis suppurativa shows resolution of inflammatory lesions and pain","volume":"140","author":"Gottlieb","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.004_bib127","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bjd\/ljae144","article-title":"Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial","volume":"191","author":"Alavi","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.004_bib128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bjd.18877","article-title":"Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:31:03Z","timestamp":1751376663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0733863524001049"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.12.004","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}